Loxo Oncology

Member Type: Emerging Biotech/Pharmaceutical Companies

Loxo Oncology is committed to the discovery, development, and commercialization of targeted cancer therapies with best-in-class potential. Their diverse pipeline reflects the convergence of proven therapeutic technologies with emerging insights into the underlying susceptibilities of cancer and drug resistance. They partner with leaders in academia and industry, allowing their management team to focus on clinical-regulatory execution in well-defined patient populations

Join Today

PMC members shape and advance the future of personalized medicine.
Join Today

Download a Member List

Member List (PDF)